Q Linea Financials
| QLINEA Stock | SEK 1.08 0.01 0.92% |
QLINEA |
Please note, the presentation of Q Linea's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Q Linea's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Q Linea's management manipulating its earnings.
Q Linea Stock Summary
Q Linea competes with Surgical Science, Bonesupport Holding, Swedencare Publ, and Oncopeptides. Q-linea AB researches, develops, manufactures, and sells instruments and disposables for infection diagnostics. Q-linea AB was founded in 2008 and is based in Uppsala, Sweden. Q Linea operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 61 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0011527845 |
| Business Address | Dag Hammarskjlds vg |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.qlinea.com |
| Phone | 46 1 84 44 36 10 |
| Currency | SEK - Swedish Kronor |
You should never invest in Q Linea without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of QLINEA Stock, because this is throwing your money away. Analyzing the key information contained in Q Linea's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Q Linea Key Financial Ratios
Q Linea's financial ratios allow both analysts and investors to convert raw data from Q Linea's financial statements into concise, actionable information that can be used to evaluate the performance of Q Linea over time and compare it to other companies across industries.QLINEA Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Q Linea's current stock value. Our valuation model uses many indicators to compare Q Linea value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Q Linea competition to find correlations between indicators driving Q Linea's intrinsic value. More Info.Q linea AB is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Q Linea by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Q Linea's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Q linea AB Systematic Risk
Q Linea's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Q Linea volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-two with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on Q linea AB correlated with the market. If Beta is less than 0 Q Linea generally moves in the opposite direction as compared to the market. If Q Linea Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Q linea AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Q Linea is generally in the same direction as the market. If Beta > 1 Q Linea moves generally in the same direction as, but more than the movement of the benchmark.
Q Linea December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Q Linea help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Q linea AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Q linea AB based on widely used predictive technical indicators. In general, we focus on analyzing QLINEA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Q Linea's daily price indicators and compare them against related drivers.
| Information Ratio | (0.34) | |||
| Maximum Drawdown | 27.87 | |||
| Value At Risk | (8.20) | |||
| Potential Upside | 5.36 |
Complementary Tools for QLINEA Stock analysis
When running Q Linea's price analysis, check to measure Q Linea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q Linea is operating at the current time. Most of Q Linea's value examination focuses on studying past and present price action to predict the probability of Q Linea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q Linea's price. Additionally, you may evaluate how the addition of Q Linea to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |